Readmission Due to Exacerbation of COPD: Associated Factors

Abstract

Objectives

To compare characteristics of patients readmitted after discharge by chronic obstructive pulmonary disease (COPD) exacerbation with those who were not readmitted and to identify factors associated with readmission risk.

Patients and Methods

We randomly selected a group of 40 COPD patients with high frequency of readmissions (HFR), who had ≥ 2 admissions by COPD exacerbation within 30 days after the last admission in 2015, and another group of 40 COPD patients with low frequency of readmissions (LFR), with 0–1 admissions in that period.

Results

Patients of the HFR group, compared to those in LFR group, were more frequently males (p = 0.009), older (p = 0.022), had a higher degree of dyspnea (p = 0.044), worse lung function (p = 0.049), belonged more frequently to exacerbator emphysema phenotype (p < 0.001), and had a higher frequency of diabetes (p = 0.049). The variables independently associated with increased risk of HFR were sex (OR 0.06, 95% CI 0.01–0.63, in women in relation to males), exacerbator emphysema phenotype (OR 28.61, 95% CI 3.59 compared to non-exacerbator phenotype), complications during hospitalization (OR 0.09, 95% CI 0.01–0.62, compared with those without complications), destabilized heart failure (OR 5.25, 95% CI 1.11–24.75, compared to those who did not), and length of hospital stay (OR 0.79, 95% CI 0.65–0.95, per day).

Conclusions

Chronic obstructive pulmonary disease patients with HFR are more frequently male, older, have worse dyspnea, lower lung function, belong more frequent to exacerbator emphysema phenotype, and more frequently diabetics. The variables that continued to be independent predictors of HFR in the multivariate analysis were sex, phenotype, occurrence of complications during admission, destabilized heart failure, and length of hospital stay.

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J et al (2017) Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med 195:557–582

    CAS  Article  PubMed  Google Scholar 

  2. 2.

    Miravitlles M, Soler-Cataluña JJ, Calle M, Molina J, Almagro P, Quintano JA et al (2017) Spanish guidelines for management of chronic obstructive pulmonary disease (GesEPOC) 2017. Pharmacological treatment of stable phase. Arch Bronconeumol 53:324–335

    PubMed  Google Scholar 

  3. 3.

    Escarrabill J, Torrente E, Esquinas C, Hernández C, Monsó E, Freixas M et al (2015) Clinical audit of patients hospitalized due to COPD exacerbation. MAG-1 study. Arch Bronconeumol 51:483–489

    PubMed  Google Scholar 

  4. 4.

    Llauger Roselló MA, Pou MA, Domínguez L, Freixas M, Valverde P, Valero C (2011) Treating COPD in chronic patients in a primary-care setting. Arch Bronconeumol 47:561–570

    Article  PubMed  Google Scholar 

  5. 5.

    Atención integral al paciente con enfermedad pulmonar crónica (EPOC) desde la atención primaria hasta la especializada. Guía de práctica clínica 2010: semFYC/ SEPAR. http://www.guiasalud.es/GPC/GPC_468_EPOC_AP_AE.pdf

  6. 6.

    Calle Rubio M, Morales Chacón B, Rodríguez Hermosa JL (2010) Exacerbation of chronic obstructive pulmonary disease. Arch Bronconeumol 46(Suppl 7):21–25

    Article  PubMed  Google Scholar 

  7. 7.

    Lindenauer PK, Dharmarajan K, Qin L, Lin Z, Gershon AS, Krumholz HM (2017) Risk trajectories of readmission and death in the first year following hospitalization for COPD. Am J Respir Crit Care Med. https://doi.org/10.1164/rccm.201709-1852OC

    Google Scholar 

  8. 8.

    Nasser R, Epstein D, Azzam R, Gofman I, Saliba W, Hardak E et al (2017) The effect of clinical and physiological instability at discharge following hospitalization for acute exacerbation of COPD on early readmission: a cohort study. Chest 151:1192–1194

    Article  PubMed  Google Scholar 

  9. 9.

    Goto T, Faridi MK, Gibo K, Toh S, Hanania NA, Camargo CA Jr et al (2017) Trends in 30-day readmission rates after COPD hospitalization, 2006–2012. Respir Med 130:92–97

    Article  PubMed  Google Scholar 

  10. 10.

    De Granda-Orive JI, Solano-Reina S (2016) Chronic obstructive pulmonary disease mortality. SEPAR COPD-Smoking year. Arch Bronconeumol 52:407–408

    PubMed  Google Scholar 

  11. 11.

    McGhan R, Radcliff T, Fish R, Sutherland ER, Welsh C, Make B (2007) Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest 132:1748–1755

    Article  PubMed  Google Scholar 

  12. 12.

    Vidal García I, Calvo Álvarez U, Lijó Carballeda C, Souto Alonso A, Diego Roza C, Mejuto Martí MJ et al (2012) Características de pacientes con EPOC ingresados por exacerbación en el área sanitaria de Ferrol. Pneuma 8:4–7

  13. 13.

    Sharif R, Parekh TM, Pierson KS, Kuo YF, Sharma G (2014) Predictors of early readmission among patients 40 to 64 years of age hospitalized for chronic obstructive pulmonary disease. Ann Am Thorac Soc 11:685–694

    Article  PubMed  PubMed Central  Google Scholar 

  14. 14.

    Lau CS, Siracuse BL, Chamberlain RS (2017) Readmission after COPD exacerbation scale: determining 30-day readmission risk for COPD patients. Int J Chron Obstruct Pulmon Dis 12:1891–1902

    Article  PubMed  PubMed Central  Google Scholar 

  15. 15.

    Roberts MH, Clerisme-Beaty E, Kozma CM, Paris A, Slaton T, Mapel DW (2016) A retrospective analysis to identify predictors of COPD-related rehospitalization. BMC Pulm Med 16:68

    Article  PubMed  PubMed Central  Google Scholar 

  16. 16.

    Nishimura K, Izumi T, Tsukino M, Oga T (2002) Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 121:1434–1440

    Article  PubMed  Google Scholar 

  17. 17.

    Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA (1999) Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54:581–586

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  18. 18.

    Gaude GS, Rajesh BP, Chaudhury A, Hattiholi J (2015) Outcomes associated with acute exacerbations of chronic obstructive pulmonary disorder requiring hospitalization. Lung India 32:465–472

    Article  PubMed  PubMed Central  Google Scholar 

  19. 19.

    Shah T, Press VG, Huisingh-Scheetz M, White SR (2016) COPD readmissions: addressing COPD in the era of value-based healthcare. Chest 150:916–926

    Article  PubMed  PubMed Central  Google Scholar 

  20. 20.

    Tsoumakidou M, Tzanakis N, Voulgaraki O, Mitrouska I, Chrysofakis G, Samiou M et al (2004) Is there any correlation between the ATS, BTS, ERS and GOLD COPD’s severity scales and the frequency of hospital admissions? Respir Med 98:178–183

    Article  PubMed  Google Scholar 

  21. 21.

    Castillo A, Edriss H, Selvan K, Nugent K (2017) Characteristics of patients with congestive heart failure or chronic obstructive pulmonary disease readmissions within 30 days following an acute exacerbation. Qual Manag Health Care 26:152–159

    Article  PubMed  Google Scholar 

  22. 22.

    Almagro P, Cabrera FJ, Díez J, Boixeda R, Alonso Ortiz MB, Murio C et al (2012) Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de medicina interna (ESMI) study. Chest 142:1126–1133

    Article  PubMed  Google Scholar 

  23. 23.

    De Miguel Díez J, Gómez García T, Puente Maestu L (2010) Comorbidities in COPD. Arch Bronconeumol 46(Suppl 11):20–25

    Article  PubMed  Google Scholar 

  24. 24.

    González G, Servera E, Ferris G, Blasco ML, Marín J (2004) Risk factors of readmission in acute exacerbation of moderate-to-severe chronic obstructive pulmonary disease. Arch Bronconeumol 40:502–507

    Article  PubMed  Google Scholar 

  25. 25.

    Simmering JE, Polgreen LA, Comellas AP, Cavanaugh JE, Polgreen PM (2016) Identifying patients with COPD at high risk of readmission. Chronic Obstr Pulm Dis 3:729–738

    PubMed  PubMed Central  Google Scholar 

  26. 26.

    Echevarria C, Steer J, Heslop-Marshall K, Stenton SC, Hickey PM, Hughes R et al (2017) The PEARL score predicts 90-day readmission or death after hospitalisation for acute exacerbation of COPD. Thorax 72:686–693

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  27. 27.

    Alfageme I, Vázquez R, Reyes N, Muñóz J, Fernández A, Hernández M et al (2006) Clinical efficacy of anti-pneumococcal vaccination in patients with COPD. Thorax 61:189–195

    CAS  Article  PubMed  Google Scholar 

  28. 28.

    Lee TA, Weaver FM, Weiss KB (2007) Impact of pneumococcal vaccination on pneumonia rates in patients with COPD and asthma. J Gen Intern Med 22:62–67

    Article  PubMed  PubMed Central  Google Scholar 

  29. 29.

    Schembri S, Morant S, Winter JH, MacDonald TM (2009) Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD. Thorax 64:567–572

    CAS  Article  PubMed  Google Scholar 

  30. 30.

    Schenkein JG, Nahm MH, Dransfield MT (2008) Pneumococcal vaccination for patients with COPD: current practice and future directions. Chest 133:767–774

    Article  PubMed  Google Scholar 

  31. 31.

    Jurado Gámez B, Feu Collado N, Jurado García JC, García Gil F, Muñoz Gomariz E, Jiménez Murillo L et al (2013) Intervención domiciliaria y variables predictoras para reingreso hospitalario en la enfermedad pulmonar obstructiva crónica agudizada. Arch Bronconeumol 49:10–14

    Article  PubMed  Google Scholar 

  32. 32.

    Groenewegen KH, Schols AM, Wouters EF (2003) Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 124:459–467

    Article  PubMed  Google Scholar 

  33. 33.

    Almagro P, Barreiro B, Ochoa de Echaguen A, Quintana S, Rodriguez Carballeira M, Heredia JL (2006) Risk factors for hospital readmission in patients with chronic obstructive pulmonary disease. Respiration 73:311–317

    Article  PubMed  Google Scholar 

  34. 34.

    Villar Álvarez F, Méndez Bailón M, De Miguel Díez J (2009) Chronic obstructive pulmonary disease and heart failure. Arch Bronconeumol 45:387–393

    Article  PubMed  Google Scholar 

  35. 35.

    Echave-Sustaeta J, Comeche Casanova L, García Luján R, Sayas Catalan J, de la Cámara AG, Encuentra AL (2010) Prognosis following acute exacerbation of COPD treated with non-invasive mechanical ventilation. Arch Bronconeumol 46:405–410

    Article  PubMed  Google Scholar 

  36. 36.

    Chu CM, Chan VL, Lin AWN, Wong IWY, Leung WS, Lai CKW (2004) Readmission rates and life threatening events in COPD survivors treated with non-invasive ventilation for acute hypercapnic respiratory failure. Thorax 59:1020–1025

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  37. 37.

    Hartl S, Lopez-Campos JL, Pozo-Rodriguez F, Castro-Acosta A, Studnicka M, Kaiser B et al (2016) Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit. Eur Respir J 47:113–121

    Article  PubMed  Google Scholar 

  38. 38.

    Maciá Soler L, Latour Pérez J, Moncho Vasallo J, Mariscal Crespo MI, Orts Cortés MI (2011) Modelo de hospitalización y frecuencia de reingreso en pacientes con exacerbación de EPOC. Enferm Glob 10:1–10

  39. 39.

    Sundararajan L, Balami J, Packham S (2010) Effectiveness of outpatient pulmonary rehabilitation in elderly patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev 30:121–125

    CAS  Article  PubMed  Google Scholar 

  40. 40.

    Williams V, Bruton A, Ellis-Hill C, McPherson K (2010) The effect of pulmonary rehabilitation on perceptions of breathlessness and activity in COPD patients: a qualitative study. Prim Care Respir J 19:45–51

    Article  PubMed  Google Scholar 

  41. 41.

    Hansen LO, Young RS, Hinami K, Leung A, Williams MV (2011) Interventions to reduce 30-day rehospitalization: a systematic review. Ann Intern Med 155:520–528

    Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Javier de Miguel-Díez.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Cerezo Lajas, A., Gutiérrez González, E., Llorente Parrado, C. et al. Readmission Due to Exacerbation of COPD: Associated Factors. Lung 196, 185–193 (2018). https://doi.org/10.1007/s00408-018-0093-y

Download citation

Keywords

  • Pulmonary disease
  • Chronic obstructive
  • Hospitalization
  • Patient discharge
  • Patient readmission